MetaADEDB 2.0 @ LMMD
1 alpha-hydroxyergocalciferol
(HKXBNHCUPKIYDM-CGMHZMFXSA-N)
Structure
SMILES
O[C@H]1C[C@H](O)C(=C)/C(=C\C=C\2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](/C=C/[C@@H](C(C)C)C)C)C)/C1
Type(s)
Approved
ATC code(s)
H05BX03
Molecular Formula:
C28H44O2
Molecular Weight:
412.648
Log P:
6.6118
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
2
TPSA:
40.46
CAS Number(s):
54573-75-0; 127516-23-8
Synonym(s)
1.
1 alpha-hydroxyergocalciferol
2.
1alpha(OH)2D2
3.
1alpha-OHD2
4.
1alpha-hydroxyvitamin D2
5.
Hectorol
6.
doxacalciferol
7.
doxercalciferol
External Link(s)
MeSHC042533
PubChem Compound5281107
46705423
ChEBI4712
CHEMBLCHEMBL1200810
DrugBankDB06410
DrugCentral957
IUPHAR/BPS Guide to PHARMACOLOGY2790
KEGGcpd:C08211
dr:D01009
Therapeutic Target DatabaseD0G5CF
ZINC4641374
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HypersensitivityFAERS: 44US FAERS
2PruritusFAERS: 37SIDER
US FAERS
3NauseaFAERS: 15OFFSIDES
SIDER
US FAERS
4FlushingFAERS: 13US FAERS
5VomitingFAERS: 13SIDER
US FAERS
6Chest discomfortFAERS: 12US FAERS
7Chest PainFAERS: 10SIDER
US FAERS
8Back PainFAERS: 9US FAERS
9DizzinessFAERS: 9OFFSIDES
SIDER
US FAERS
10Medication ErrorFAERS: 9US FAERS
11UrticariaFAERS: 9US FAERS
12PalpitationsFAERS: 8US FAERS
13ErythemaFAERS: 6OFFSIDES
US FAERS
14Blood parathyroid hormone increasedFAERS: 5OFFSIDES
US FAERS
15Feeling abnormalFAERS: 5OFFSIDES
SIDER
US FAERS
16Respiratory distressFAERS: 5US FAERS
17SwellingFAERS: 5US FAERS
18HeadacheFAERS: 4SIDER
US FAERS
19MalaiseFAERS: 4SIDER
US FAERS
20Mental status changesFAERS: 4US FAERS
21PainFAERS: 4OFFSIDES
US FAERS
22AnxietyFAERS: 3OFFSIDES
US FAERS
23ConstipationFAERS: 3SIDER
US FAERS
24HyperparathyroidismFAERS: 3OFFSIDES
US FAERS
25Lip swellingFAERS: 3US FAERS
26Respiratory arrestFAERS: 3US FAERS
27Throat irritationFAERS: 3US FAERS
28Unevaluable eventFAERS: 3US FAERS
29Unresponsive to stimuliFAERS: 3OFFSIDES
US FAERS
30Abdominal discomfortFAERS: 2OFFSIDES
US FAERS
31ArthralgiaFAERS: 2SIDER
US FAERS
32Blood parathyroid hormone abnormalFAERS: 2US FAERS
33Bone painFAERS: 2OFFSIDES
SIDER
US FAERS
34Drug dispensing errorFAERS: 2US FAERS
35Drug ineffectiveFAERS: 2US FAERS
36DysgeusiaFAERS: 2SIDER
US FAERS
37HypotensionFAERS: 2US FAERS
38Nipple painFAERS: 2US FAERS
39OverdoseFAERS: 2US FAERS
40Rash erythematousFAERS: 2US FAERS
41TachycardiaFAERS: 2US FAERS
42AbscessFAERS: 1SIDER
US FAERS
43AgitationFAERS: 1US FAERS
44AngioedemaFAERS: 1US FAERS
45AphagiaFAERS: 1US FAERS
46AstheniaFAERS: 1OFFSIDES
SIDER
US FAERS
47Blood glucose decreasedFAERS: 1US FAERS
48Blood magnesium decreasedFAERS: 1US FAERS
49Blood phosphorus increasedFAERS: 1OFFSIDES
US FAERS
50BradycardiaFAERS: 1SIDER
US FAERS
51Breast tendernessFAERS: 1US FAERS
52Burning sensationFAERS: 1OFFSIDES
US FAERS
53CalcinosisFAERS: 1SIDER
US FAERS
54CalciphylaxisFAERS: 1OFFSIDES
US FAERS
55Central Nervous System InfectionFAERS: 1US FAERS
56Cerebrovascular accidentFAERS: 1US FAERS
57Choking sensationFAERS: 1OFFSIDES
US FAERS
58CyanosisFAERS: 1OFFSIDES
US FAERS
59Depressed Level of ConsciousnessFAERS: 1US FAERS
60DiscomfortFAERS: 1SIDER
US FAERS
61Dry skinFAERS: 1OFFSIDES
US FAERS
62DyspepsiaFAERS: 1SIDER
US FAERS
63DysphoniaFAERS: 1US FAERS
64FatigueFAERS: 1OFFSIDES
US FAERS
65Fluid overloadFAERS: 1OFFSIDES
US FAERS
66Food AllergyFAERS: 1US FAERS
67GangreneFAERS: 1OFFSIDES
US FAERS
68Incorrect dose administeredFAERS: 1US FAERS
69Incorrect route of drug administrationFAERS: 1US FAERS
70InfectionFAERS: 1SIDER
US FAERS
71InflammationFAERS: 1US FAERS
72Injury associated with deviceFAERS: 1US FAERS
73Intestinal ObstructionFAERS: 1OFFSIDES
US FAERS
74Medical device complicationFAERS: 1OFFSIDES
US FAERS
75MoaningFAERS: 1US FAERS
76Musculoskeletal stiffnessFAERS: 1OFFSIDES
US FAERS
77Myocardial InfarctionFAERS: 1US FAERS
78NervousnessFAERS: 1US FAERS
79No reaction on previous exposure to drugFAERS: 1OFFSIDES
US FAERS
80Occupational exposure to productFAERS: 1US FAERS
81Pancreatic carcinomaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
82PancreatitisFAERS: 1OFFSIDES
SIDER
US FAERS
83Product barcode issueFAERS: 1US FAERS
84Skin reactionFAERS: 1US FAERS
85SyncopeFAERS: 1US FAERS
86TremorFAERS: 1US FAERS
87Unresponsive to verbal stimuliFAERS: 1OFFSIDES
US FAERS
88Urinary tract infectionFAERS: 1SIDER
US FAERS
89Vitamin D DeficiencyFAERS: 1US FAERS
90furuncleFAERS: 1US FAERS
91AbasiaOFFSIDES
92Abdominal PainOFFSIDES
93Abdominal adhesionsOFFSIDES
94Acid refluxOFFSIDES
95Acute myocardial infarctionOFFSIDES
96AlbuminuriaSIDER
97AlopeciaOFFSIDES
98AngiokeratomaOFFSIDES
99AnorexiaOFFSIDES
SIDER
100Aortic AneurysmOFFSIDES
101ApathyOFFSIDES
SIDER
102ArteriosclerosisOFFSIDES
103Arteriovenous fistula occlusionOFFSIDES
104Arteriovenous fistula thrombosisOFFSIDES
105Aspartate Aminotransferase IncreasedSIDER
106Bacillus infectionOFFSIDES
107Bacterial sepsisOFFSIDES
108BiopsyOFFSIDES
109Blood GlucoseOFFSIDES
110Blood immunoglobulin EOFFSIDES
111Blood iron increasedOFFSIDES
112Blood potassium decreasedOFFSIDES
113Blood pressure fluctuationOFFSIDES
114Blood pressure inadequately controlledOFFSIDES
115Blood urea increasedOFFSIDES
SIDER
116Blurred visionOFFSIDES
117Breast MicrocalcificationOFFSIDES
118Breast hyperplasiaOFFSIDES
119Cardiac enzymes increasedOFFSIDES
120Catheter related complicationOFFSIDES
121Catheter site erythemaOFFSIDES
122Cerebral atrophyOFFSIDES
123Circumstance or information capable of leading to medication errorOFFSIDES
124ConfabulationOFFSIDES
125ConjunctivitisSIDER
126DehydrationOFFSIDES
SIDER
127DemyelinationOFFSIDES
128DiabetesOFFSIDES
129Diabetic NephropathyOFFSIDES
130Diabetic RetinopathyOFFSIDES
131Dialysis device insertionOFFSIDES
132Dialysis disequilibrium syndromeOFFSIDES
133DiarrheaOFFSIDES
134DiplopiaOFFSIDES
135Disturbance in sexual arousalSIDER
136Drug withdrawal headacheOFFSIDES
137Economic problemOFFSIDES
138Emotional distressOFFSIDES
139EndocarditisOFFSIDES
140Endotracheal intubation complicationOFFSIDES
141Enterococcal infectionOFFSIDES
142Erosive gastritisOFFSIDES
143Fibroadenoma of breastOFFSIDES
144Flat affectSIDER
145Focal glomerulosclerosisOFFSIDES
146FormicationOFFSIDES
147Haptoglobin DecreasedOFFSIDES
148HemiparesisOFFSIDES
149HerniaOFFSIDES
150HyperkeratosisOFFSIDES
151IncoherentOFFSIDES
152Infusion site mobility decreasedOFFSIDES
153Initial insomniaOFFSIDES
154IntoxicationSIDER
155Joint InstabilityOFFSIDES
156Joint Range of Motion DecreasedOFFSIDES
157Joint stiffnessOFFSIDES
158Kidney FailureOFFSIDES
159LethargyOFFSIDES
160Limb discomfortOFFSIDES
161Malignant HypertensionOFFSIDES
162Metabolic acidosisOFFSIDES
163Metastatic NeoplasmOFFSIDES
164Methylmalonic aciduriaOFFSIDES
165MononeuritisOFFSIDES
166Muscle WeaknessOFFSIDES
167Muscle tightnessOFFSIDES
168Musculoskeletal chest painOFFSIDES
169Musculoskeletal discomfortSIDER
170MyalgiaSIDER
171NasopharyngitisSIDER
172Nephrogenic Fibrosing DermopathyOFFSIDES
173NocturiaSIDER
174Open woundOFFSIDES
175PallorOFFSIDES
176PeritonitisOFFSIDES
177PhotophobiaSIDER
178PoisoningSIDER
179PolydipsiaSIDER
180PolyuriaSIDER
181Post procedural dizzinessOFFSIDES
182Post-traumatic painOFFSIDES
183Propionibacterium infectionOFFSIDES
184Pulmonary HypertensionOFFSIDES
185PyelonephritisOFFSIDES
186Quality of life decreasedOFFSIDES
187Respiratory FailureOFFSIDES
188Retinal Vein OcclusionOFFSIDES
189RhinitisSIDER
190Skin IndurationOFFSIDES
191Skin hypertrophyOFFSIDES
192Skin lesionOFFSIDES
193Skin tightnessOFFSIDES
194SomnolenceSIDER
195Status EpilepticusOFFSIDES
196Stevens-Johnson SyndromeOFFSIDES
197Subcutaneous noduleOFFSIDES
198Urine output increasedSIDER
199Visual disturbanceOFFSIDES
200Vitamin B 12 DeficiencyOFFSIDES
201Weight decreasedSIDER
202bone marrow fibrosisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.